AS
Insider selling
Andrew Stewart Plump sold $2.1M of Takeda Pharmaceutical Co Ltd (TAK) stock
Andrew Stewart Plump, President, R&D of Takeda Pharmaceutical Co Ltd (TAK), sold 116,191 shares of TAK stock worth $2.1M, per an SEC Form 4 filed Sep 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 2, 2026, 2 days before it was made public.
TAK has moved +1.6% since the trade date, from $18.43 to $18.73 (Oct 9, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 4, 2026
- Filing delay
- 2 days
- Price since
- +1.6%
- Role
- President, R&D
- Source
- SEC Form 4
More TAK insider and Congress trades
- SellTAK · Lauren Rusckowski Duprey$640KSep 16, 2026
- SellTAK · Andrew Stewart Plump$363KAug 21, 2026
- SellTAK · Nicola Deidre Petal Greenway$235KAug 19, 2026
- SellTAK · Lauren Rusckowski Duprey$814KAug 13, 2026
- SellTAK · Rhonda Janice Pacheco$289KAug 13, 2026
- SellTAK · Awny Samaan Botros Farajallah$240KAug 13, 2026
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.